This medication treats an issue that affects patients of all ages, some associated with Covid infection. Here's why ...

Opus Genetics (IRD) announced that a presentation featuring the LYNX-1 Phase 3 study of Phentolamine Ophthalmic Solution 0.75% in patients with ...

Ointments have the advantage of increased dwell time in the eye, but often patients and parents of children prefer drops, and no therapeutic advantage of one over the other has been demonstrated.

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the ...

Miebo produced substantial symptom relief in patients with dry eye disease during the first day and succeeding weeks of ...

GROUPE LSL PHARMA INC (TSXV: LSL) (TSXV: LSL.DB) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical ...

Michelle Hessen, OD, discusses how cyclosporine ophthalmic solution 0.09% is safe to use in patients with dry eye, as well as where future research should turn. Michelle Hessen, OD, assistant ...

(RTTNews) - Glenmark Pharmaceuticals Inc., USA announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its Olopatadine Hydrochloride Ophthalmic Solution ...

Glenmark has received the Food and Drug Administration’s clearance for olopatadine hydrochloride ophthalmic solution, 0.2% ...

Three abstracts on our investigational gene therapy candidates have been accepted for presentation at the ARVO 2025 Meeting, to take place from ...

and Opti-Free Express MultiPurpose Disinfecting Solution (Alcon), as well as other storage solutions for contact lenses. SofZia™ is the most recent advancement in the field of ophthalmic ...